Nurix Therapeutics, Inc.
NRIX
Revenue
12.59M
▲496.00k▲4.10%
3 Months ChangeAssets
513.60M
▲2.57M▲0.5027%
3 Months ChangeLiabilities
136.74M
▼-3.59M▼-2.56%
3 Months ChangeFree Cash Flow
-44.84M
▲5.89M▲11.62%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248678
2024-10-16
Form 8-K
ID: 0001549595-24-000138
2024-10-11
Form 10-Q
ID: 0001549595-24-000131
2024-10-11
Form 8-K
ID: 0001549595-24-000130
2024-09-05
Form 8-K
ID: 0001549595-24-000120
2024-07-11
Form 10-Q
ID: 0001549595-24-000098
2024-07-11
Form 8-K
ID: 0001549595-24-000097
2024-06-17
Form 8-K
ID: 0001549595-24-000086
2024-05-21
Form 8-K
ID: 0001549595-24-000073
2024-04-12
Form 8-K
ID: 0001193125-24-094875